{"id":819746,"date":"2025-02-28T02:03:07","date_gmt":"2025-02-28T07:03:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/"},"modified":"2025-02-28T02:03:07","modified_gmt":"2025-02-28T07:03:07","slug":"pharming-group-to-participate-in-march-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/","title":{"rendered":"Pharming Group to participate in March investor conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">\n        <strong>Leiden, the\u00a0<\/strong><br \/>\n        <strong>Netherlands, February 28, 2025: <\/strong>Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of March:<\/p>\n<ul type=\"disc\">\n<li style=\"margin-bottom:6pt;text-align:left\">\n          <strong>37<\/strong><br \/>\n          <sup><br \/>\n            <strong>th<\/strong><br \/>\n          <\/sup><br \/>\n          <strong> Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025<\/strong><br \/>\n          <br \/>Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT\/21:30 CET.<\/li>\n<\/ul>\n<p align=\"justify\">For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7pZiGhdPnoO-QQ3c4vcRwdvHQLzc1Gv9Y_JKqxeohdd9kpFxXBKKbYwdL6RZ2C77hWwRQ_Ppq7KkwpJliCRx5lw1DYppAiOkgJnsCxTRbL0=\" rel=\"nofollow\" target=\"_blank\">investor@pharming.com<\/a> or your Roth representative.<\/p>\n<p align=\"justify\">\n        <strong>About Pharming Group N.V.<\/strong><br \/>\n        <br \/>Pharming Group N.V. (EURONEXT Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. <\/p>\n<p align=\"justify\">For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=bXPdG5B9C8AFyFGI5bG-rs4enflh_jZXJkVBk94FflXSh9wN-Vzu7vBOQx73d1TtkQPyP-hK5cH1jTqa6GIaydKytjJFSJhEiZS44AUEOZw=\" rel=\"nofollow\" target=\"_blank\">www.pharming.com<\/a> and find us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GPFQAVUT385yiUQuUVNzElCj1QtMAYK2gcwOxscp9nv_cwz3wCSxbZu102tcEFXRIcIv0NQcn9M_6XEGD_Xh01Pt8U12Rhemj_Mll85zwiM=\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p align=\"justify\">\n        <strong>For further public information, contact:<\/strong><br \/>\n        <br \/>\n        <em>Pharming Group, Leiden, the Netherlands<\/em><br \/>\n        <br \/>Michael Levitan, VP Investor Relations &amp; Corporate Communications<br \/>T: +1 (908) 705 1696<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7pZiGhdPnoO-QQ3c4vcRwdvHQLzc1Gv9Y_JKqxeohdeTiSJR7a-PpfY-pPNYqZRwb5YZnOWpx5q2XLcaIU1-EY7DhGPoV3pYsaW9mM2CgPg=\" rel=\"nofollow\" target=\"_blank\">investor@pharming.com<\/a><\/p>\n<p align=\"left\">\n        <em>FTI Consulting, London, United Kingdom<\/em><br \/>\n        <br \/>Simon Conway\/Alex Shaw\/Amy Byrne<br \/>T: +44 203 727 1000<\/p>\n<p align=\"left\">\n        <em>LifeSpring Life Sciences Communication, Amsterdam, the Netherlands<\/em><br \/>\n        <br \/>Leon Melens<br \/>T: +31 6 53 81 64 27<br \/>E: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SEFEYuUJRsZIwcr09z9wwxquw_CGjLMxo9FiL2e3hdBjXC86b57j7Jg4xwvKoBAvSlsn-YutON-oyW_YA3LGTlLWoYzKSUQDtK7Sni1wiGE=\" rel=\"nofollow\" target=\"_blank\">pharming@lifespring.nl<\/a><\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/b8ac376f-d007-4e13-af99-80a31af8a591\">Pharming attending Investor Conferences March 2025_EN_28FEB25<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/NGJiZDk3MWYtODlkZi00NzMwLWEzZWEtYmNlZDc4YmQxMTg1LTEwMTI1NDk=\/tiny\/Pharming-Group-N-V-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Leiden, the\u00a0 Netherlands, February 28, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of March: 37 th Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025 Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT\/21:30 CET. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Roth representative. About Pharming Group N.V. Pharming Group N.V. (EURONEXT Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Pharming Group to participate in March investor conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-819746","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pharming Group to participate in March investor conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharming Group to participate in March investor conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Leiden, the\u00a0 Netherlands, February 28, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of March: 37 th Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025 Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT\/21:30 CET. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Roth representative. About Pharming Group N.V. Pharming Group N.V. (EURONEXT Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to &hellip; Continue reading &quot;Pharming Group to participate in March investor conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-28T07:03:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Pharming Group to participate in March investor conference\",\"datePublished\":\"2025-02-28T07:03:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/\"},\"wordCount\":259,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/\",\"name\":\"Pharming Group to participate in March investor conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\",\"datePublished\":\"2025-02-28T07:03:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/pharming-group-to-participate-in-march-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharming Group to participate in March investor conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharming Group to participate in March investor conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"Pharming Group to participate in March investor conference - Market Newsdesk","og_description":"Leiden, the\u00a0 Netherlands, February 28, 2025: Pharming Group N.V. (\u201cPharming\u201d) (Euronext Amsterdam: PHARM\/Nasdaq: PHAR) announces that Pharming\u2019s management will participate in the following investor conference in the month of March: 37 th Annual Roth Conference, Dana Point, CA, USA, March 16-18, 2025 Anurag Relan, Chief Medical Officer, and Michael Levitan, VP Investor Relations and Corporate Communications, will participate in a fireside chat question and answer session on Monday, March 17 at 01:30pm PT\/21:30 CET. For more information about this conference, or to schedule a one-to-one meeting with Pharming\u2019s management team, please contact Pharming\u2019s Investor Relations team at investor@pharming.com or your Roth representative. About Pharming Group N.V. Pharming Group N.V. (EURONEXT Amsterdam: PHARM\/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to &hellip; Continue reading \"Pharming Group to participate in March investor conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2025-02-28T07:03:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Pharming Group to participate in March investor conference","datePublished":"2025-02-28T07:03:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/"},"wordCount":259,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/","name":"Pharming Group to participate in March investor conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==","datePublished":"2025-02-28T07:03:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMTA1MDkzOSM0MDIwNjc1MjQjMjAwMDk3Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/pharming-group-to-participate-in-march-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Pharming Group to participate in March investor conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819746","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=819746"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/819746\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=819746"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=819746"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=819746"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}